1-10. (canceled)
11. A method for drying under reduced pressure with which a solvent in a coating liquid is dried by placing a substrate having the coating liquid applied in a pressure-reduced atmosphere, comprising the steps of:
mounting the substrate on a substrate mount portion provided in an airtight container;
positioning a straightening vane so as to face a surface of the substrate mounted on the substrate mount portion with a gap interposed;
evacuating and reducing pressure in the airtight container down to a pressure at which a solvent component actively evaporates from said coating liquid; and
varying a flow rate set value at least in two steps while the solvent component is actively evaporating from said coating liquid.
12. The method for drying under reduced pressure according to claim 11, wherein
the step of varying a flow rate set value at least in two steps while the solvent component is actively evaporating from said coating liquid is the step of varying the flow rate set value from one to another among a first flow rate set value and a second flow rate set value larger than the first flow rate set value.
13. The method for drying under reduced pressure according to claim 12, wherein
a timing for switching between the first flow rate set value and the second flow rate set value is a timing attaining evenness in a peripheral portion of the coating film better than in a case where evacuation has been continued based on the first flow rate set value or in a case where evacuation has been continued based on the second flow rate set value while the solvent is actively evaporating from said coating liquid.
14. The method for drying under reduced pressure according to claim 11, wherein
said step of reducing pressure down to a pressure at which the solvent component actively evaporates from said coating liquid includes the step of reducing pressure until the pressure in said airtight container is set so as to be slightly higher than a pressure at which the solvent at room temperature attains to a boiling point in said airtight container in which pressure has been reduced.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A method for delivering cardiac resynchronization therapy to a patient’s heart with a cardiac rhythm management (CRM) device, the steps of the method comprising:
a) acquiring signals representing baseline cardiac electrical activity in the patient’s heart using electrocardiograph surface-lead electrodes;
b) forming a baseline model of ventricular conduction using the signals acquired in step a);
c) iteratively modifying the baseline model formed in step b) to minimize ventricular electrical asynchrony;
d) generating an updated model of global ventricular conduction that is indicative of ventricular activation wavefront fusion using the iteratively modified baseline model; and
e) converting the updated model into pacing control parameters for the CRM device using a QRS hieroglyph morphological framework.
2. The method as recited in claim 1 in which step b) includes characterizing a baseline ventricular activation sequence in the signals acquired in step a).
3. The method as recited in claim 2 in which the baseline ventricular activation sequence is characterized by identifying components of a ventricular activation sequence.
4. The method as recited in claim 3 in which the identified components include right ventricular activation time (VAT), left VAT, scar volume, QRS duration, and electrical axis.
5. The method as recited in claim 2 in which the baseline model formed in step b) duplicates a patient-specific QRS hieroglyphic signature for global baseline ventricular conduction indicated by the ventricular activation sequence.
6. The method as recited in claim 1 in which the baseline model is iteratively modified in step c) using simulated pacing control parameters.
7. The method as recited in claim 6 in which the simulated pacing control parameters include monochamber ventricular timing, cross-chamber ventricular timing, cross-chamber atrial-ventricular timing, and varying stimulation strength and pulse duration.
8. The method as recited in claim 1 in which step e) includes generating QRS glyph templates that are surrogates for QRS hieroglyphic signatures indicative of ventricular activation fusion.
9. A cardiac implantable electrical device for delivering cardiac resynchronization therapy to a patient’s heart, the cardiac implantable electrical device comprising:
an input for receiving signals indicative of baseline cardiac electrical activity in the heart from electrocardiography surface leads;
an impulse delivery system for delivering electrical impulses to the heart in order to provide cardiac resynchronization therapy thereto;
a memory for storing pacing control parameters;
a processor in communication with the memory, the processor being configured to:
receive the received signals representing baseline cardiac electrical activity in the patient’s heart;
form a baseline model of ventricular conduction using the received signals;
iteratively modify the baseline model to minimize ventricular electrical asynchrony;
generate an updated model of global ventricular conduction that is indicative of ventricular activation wavefront fusion using the iteratively modified baseline model;
convert the updated model into pacing control parameters using a QRS hieroglyph morphological framework; and
communicate with the impulse delivery system to provide cardiac resynchronization therapy to the heart in accordance with the pacing control parameters.
10. The cardiac implantable electrical device as recited in claim 9 in which the processor is further configured to form a baseline model of ventricular conduction by characterizing a baseline ventricular activation sequence in the received signals.
11. The cardiac implantable electrical device as recited in claim 10 in which the processor is configured to characterize the baseline ventricular activation sequence by identifying components of a ventricular activation sequence.
12. The cardiac implantable electrical device as recited in claim 11 in which the identified components include right ventricular activation time (VAT), left VAT, scar volume, QRS duration, and electrical axis.
13. The cardiac implantable electrical device as recited in claim 10 in which the processor is configured to form the baseline model by duplicating a patient-specific QRS hieroglyphic signature for global baseline ventricular conduction indicated by the ventricular activation sequence.
14. The cardiac implantable electrical device as recited in claim 9 in which the processor is configured to iteratively modify the baseline model using simulated pacing control parameters.
15. The cardiac implantable electrical device as recited in claim 14 in which the simulated pacing control parameters include monochamber ventricular timing, cross-chamber ventricular timing, cross-chamber atrial-ventricular timing, and varying stimulation strength and pulse duration.
16. The cardiac implantable electrical device as recited in claim 9 in which the processor is configured to generate the updated model by generating QRS glyph templates that are surrogates for QRS hieroglyphic signatures indicative of ventricular activation fusion.